# FDA 483 - Quality Blending, Inc - January 30, 2020

Source: https://www.keypedia.com/records/483/quality-blending-inc/036a0875-23ad-473f-93d7-33a43b1b40b8

> FDA 483 for Quality Blending, Inc on January 30, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Quality Blending, Inc
- Inspection Date: 2020-01-30
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: Quality Blending, Inc. in Anoka, MN, a veterinary and OTC drug manufacturer, was cited for significant deficiencies in its quality control unit during an FDA inspection. Observations included the release of out-of-specification finished products, inadequate testing of raw materials and active ingredients, incomplete batch records, and a lack of temperature monitoring and staff training procedures. Additionally, batch production records were found to be missing copies of product labeling.

## Related Officers

- [Jonathan G Gayechuway](https://www.keypedia.com/people/jonathan-g-gayechuway/25f2cb7c-89c5-40d0-96bb-aac9fe374c47)
- [Pharmacist at U.S. Public Health Service Commissioned Corps](https://www.keypedia.com/people/anthony-j-ladner/dbb6b53a-80d1-4b47-ae42-6eb2053dfa4b)

Company: https://www.keypedia.com/companies/quality-blending-inc/f0fa49f0-d0c3-4e5b-8971-8817713ac907

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d